GSK leads FTSE to gains after rebuffing Unilever move

London’s top flight ended the day 68.28 points, or 0.91%, higher at 7,611.23 points.

Pa City Staff
Monday 17 January 2022 17:49
GSK was among the strongest on the index (PA)
GSK was among the strongest on the index (PA)

The FTSE 100 struck its latest pandemic high after it was lifted by strong trading in Asia and a leap for pharmaceutical giant GlaxoSmithKline (GSK).

GSK was among the strongest on the index after weekend confirmation that fellow FTSE firm Unilever had a roughly £50 billion approach for its consumer health business knocked back.

Unilever investors were less happy about the news, but the takeover interest helped boost the price of other listed consumer firms.

London’s top flight ended the day 68.28 points, or 0.91%, higher at 7,611.23 points.

Michael Hewson, chief market analyst at CMC Markets UK, said: “It’s been a quiet but positive start to the week for markets in Europe, after Asia markets largely got the week off to a positive start, after the People’s Bank of China unexpectedly eased monetary policy.

“The FTSE 100 has had another good day, moving above the 7,600 level, to another post-lockdown high, helped largely by M&A activity with the weekend news of Unilever’s bid for GlaxoSmithKline’s consumer goods business, reinforcing the truth that a lot of companies on the UK’s benchmark index are seriously undervalued.”

GSK investors, who have been expecting the consumer spin-off to float later this year, were boosted by the confirmation of takeover offers. It sent the firm’s shares 66.8p higher to 1,707.8p.

However, Unilever was greeted by criticism from analysts, such as brokers at Barclays who downgraded its stock in response.

The Marmite and Dove soap manufacturer finished the day 274.5p lower at 3,662p.

Meanwhile, Europe’s other major markets were also in the green on Monday as they soaked up positive trading sentiment from Asia while Wall Street was on hold due to the Martin Luther King Jr Day holiday.

The German Dax increased by 0.34% and the French Cac rose by 0.93%.

Elsewhere, sterling was calm amid the closure of the US markets, as the pound stayed flat versus the US dollar at 1.364, and decreased 0.01% against the euro at 1.196.

In company news, housebuilder Taylor Wimpey climbed after it said a spike in the price of its homes fully made up for the soaring costs of staff and building materials.

Taylor Wimpey’s boss said the firm delivered an “excellent performance” last year, and that demand remains strong for the company’s newly-built homes, which became £12,000 more expensive.

The company saw shares rise by 6.45p to 160.4p at the close of play.

Cyber security company Darktrace slid in value after criticism from short-seller ShadowFall that its business model is “watery-thin” and will not stand the test of time.

Darktrace closed 31.4p lower at 413.2p after the hedge fund said the company’s addressable market is nowhere near as large as its bosses claim.

The price of oil kept up its recent momentum to strike a new three-year high but then stagnated later in the trading day as Libya reported an increase in output.

Brent crude increased by 0.24% to 86.27 dollars per barrel when the London markets closed.

The biggest risers on the FTSE 100 were Taylor Wimpey, up 6.45p at 160.4p; Admiral, up 130p at 3,241p; Antofagasta, up 57.5p at 1,436.5p; and GSK, up 66.8p at 1,707.8p.

The biggest fallers on the FTSE 100 were Unilever, down 274.5p at 3,662p; Flutter, down 150p at 11,125p; Evraz, down 6.8p at 573p; and Polymetal, down 8.5p at 1,154p.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in